TY - JOUR
T1 - A functional role for eicosanoid-lysophospholipids in activating monocyte signaling
AU - Liu, Gao Yuan
AU - Moon, Sung Ho
AU - Jenkins, Christopher M.
AU - Sims, Harold F.
AU - Guan, Shaoping
AU - Gross, Richard W.
N1 - Funding Information:
Funding and additional information—This work was supported by the NIH National Heart, Lung, and Blood Institute (NHLBI) grants R01HL118639 (to R. W. G.) and R01HL133178 (to R. W. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding Information:
This work was supported by the NIH National Heart, Lung, and Blood Institute (NHLBI) grants R01HL118639 (to R. W. G.) and R01HL133178 (to R. W. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2020 Liu et al. Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2020/8/21
Y1 - 2020/8/21
N2 - Recently, eicosanoid-lysophospholipids were identified as novel metabolites generated from the direct cyclooxygenase- or lipoxygenase-catalyzed oxidation of 2-arachidonoyl-lysophos-pholipids produced from either phospholipase A1-mediated hydrolysis of diacyl arachidonoyl-phospholipids or through the cytochrome c-catalyzed oxidative hydrolysis of the vinyl ether linkage of arachidonoyl-plasmalogens. Although the metabolic pathways generating eicosanoid-lysophospholipids have been increasingly appreciated, the signaling functions of eicosanoid-lysophospholipids remain largely unknown. Herein, we demonstrate that 2-12(S)-HETE-lysophospholipids as well as nonesterified 12(S)-HETE are potent lipid mediators that activate THP-1 human monocytic cells to generate tumor necrosis factor a (TNFa) and interleukin 8 (IL8). Remarkably, low nanomolar concentrations of 12(S)-HETE-lysophospholipids, but not other oxidized signaling lipids examined activated THP-1 cells resulting in the production of large amounts of TNFa. Moreover, TNFa release induced by 12(S)-HETE-lysophospholipids was inhibited by the TNFa converting enzyme inhibitor TAPI-0 indicating normal processing of TNFa in THP-1 cells stimulated with these agonists. Western blotting analyses revealed that 12 (S)-HETE-lysophospholipids activated the phosphorylation of NFkB p65, suggesting activation of the canonical NFkB signaling pathway. Importantly, activation of THP-1 cells to release TNFa was stereoselective with 12(S)-HETE favored over 12(R)-HETE. Furthermore, the EC50 of 2-12(S)-HETE-lysophosphatidylcholine in activating THP-1 cells was 2.1 nM, whereas the EC50 of free 12 (S)-HETE was 23 nM. Additionally, lipid extracts of activated platelets were separated by RP-HPLC demonstrating the coelution of 12(S)-HETE with fractions initiating TNFa release. Collectively, these results demonstrate the potent signaling properties of 2-12(S)-HETE-lysophospholipids and 12(S)-HETE by their ability to release TNFa and activate NFkB signaling thereby revealing a previously unknown role of 2-12(S)-HETE-lysophospholipids in mediating inflammatory responses.
AB - Recently, eicosanoid-lysophospholipids were identified as novel metabolites generated from the direct cyclooxygenase- or lipoxygenase-catalyzed oxidation of 2-arachidonoyl-lysophos-pholipids produced from either phospholipase A1-mediated hydrolysis of diacyl arachidonoyl-phospholipids or through the cytochrome c-catalyzed oxidative hydrolysis of the vinyl ether linkage of arachidonoyl-plasmalogens. Although the metabolic pathways generating eicosanoid-lysophospholipids have been increasingly appreciated, the signaling functions of eicosanoid-lysophospholipids remain largely unknown. Herein, we demonstrate that 2-12(S)-HETE-lysophospholipids as well as nonesterified 12(S)-HETE are potent lipid mediators that activate THP-1 human monocytic cells to generate tumor necrosis factor a (TNFa) and interleukin 8 (IL8). Remarkably, low nanomolar concentrations of 12(S)-HETE-lysophospholipids, but not other oxidized signaling lipids examined activated THP-1 cells resulting in the production of large amounts of TNFa. Moreover, TNFa release induced by 12(S)-HETE-lysophospholipids was inhibited by the TNFa converting enzyme inhibitor TAPI-0 indicating normal processing of TNFa in THP-1 cells stimulated with these agonists. Western blotting analyses revealed that 12 (S)-HETE-lysophospholipids activated the phosphorylation of NFkB p65, suggesting activation of the canonical NFkB signaling pathway. Importantly, activation of THP-1 cells to release TNFa was stereoselective with 12(S)-HETE favored over 12(R)-HETE. Furthermore, the EC50 of 2-12(S)-HETE-lysophosphatidylcholine in activating THP-1 cells was 2.1 nM, whereas the EC50 of free 12 (S)-HETE was 23 nM. Additionally, lipid extracts of activated platelets were separated by RP-HPLC demonstrating the coelution of 12(S)-HETE with fractions initiating TNFa release. Collectively, these results demonstrate the potent signaling properties of 2-12(S)-HETE-lysophospholipids and 12(S)-HETE by their ability to release TNFa and activate NFkB signaling thereby revealing a previously unknown role of 2-12(S)-HETE-lysophospholipids in mediating inflammatory responses.
UR - http://www.scopus.com/inward/record.url?scp=85089814425&partnerID=8YFLogxK
U2 - 10.1074/jbc.ra120.013619
DO - 10.1074/jbc.ra120.013619
M3 - Article
C2 - 32641497
AN - SCOPUS:85089814425
SN - 0021-9258
VL - 295
SP - 12167
EP - 12180
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 34
ER -